Boston Scientific (BSX) has canceled a deal to acquire a majority stake in the Korean medical device maker M.I.Tech for $230M amid antitrust issues. Read more here.

Original Image Link
Source:www.msn.com

Original Image Link
Source:www.msn.com
Posted: 2023-05-25 03:56:57